RankAlpha logo
Back to Rankings

CGEN

CompugenB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The Q2 revenue and EPS results appear better than the packet's pre-print consensus, while the company reiterated its MAIA-ovarian timing, partner-program progress, and runway into 2029. A successful interim PFS result could support substantial upside.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
MAIA-ovarian interim PFS data could disappoint, be delayed, or fail to establish a registration path.
Momentum
89
Value
56
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.40 · Bull $4.60 · Bear $1.40Analysis 2026-08-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-06 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $4.60
Why
Momentum89 · Δ7d -
Value56 · Δ7d -0.0
Sentiment66 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • • MAIA-ovarian interim PFS data could disappoint, be delayed, or fail to establish a registration path.
  • • Post-earnings analyst revisions and a clean event-specific market-reaction attribution were not available in the bounded evidence.
  • • CGEN remains a low-coverage, clinical-stage biotech with no established product revenue base.

Catalyst clock

2026-08-03

Q2 2026 beat improved near-term tone

Lead driver: Sentiment · See AI snapshot
Momentum
89
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
56
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
0.0
Sentiment
66
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 89.1 / Value 56.4 / Sentiment 66.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-06. Scenario method

B+
Bull case
20%
Probability
Target price
$4.60
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$2.40
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.40
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$222.2M
Beta
1.61
Shares Out
94.55M
P/E (TTM) · Derived
6.2
P/S (TTM)
21.00
P/FCF (TTM)
2.93
Rev YoY
+107.0%
EPS YoY
-5.7%
Gross Margin
+86.9%
Op Margin
+40.9%
Net Debt
-$142.68M
Current Ratio
5.72
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data